Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00004547 · FLOW

Participant flow

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy · Source last updated 2015-11-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Patients with peritoneal mesothelioma suffer with intractable ascites but have a very surface oriented tumor which usually does not invade into organs and cause organ dysfunction. The main source of symptoms and cause of death is intractable ascites.
    id
    FG000
    title
    Peritoneal Mesothelioma
  2. description
    Low grade mucinous adenocarcinoma also includes low grade mucinous neoplasms of borderline malignant potential. Patients with low grade mucinous adenocarcinoma can have prolonged survival with debulking surgery alone. The majority of patients with truly malignant disease will die of complications from intraperitoneal progression of tumor within 2 to 5 years. The tumors are often surface oriented within the peritoneal cavity without metastases to other distant sites. The most common origin for this type of tumor is the appendix and ovary.
    id
    FG001
    title
    Low Grade Mucinous Adenocarcinoma
  3. description
    Adenocarcinoma of gastrointestinal origin also includes other than low grade mucinous. Aggressive gastrointestinal adenocarcinomas such as gastric, small bowel, and colon cancer , tend to be more invasive into tissues and can more readily metastasize to distant sites. The cause of death is usually directly related to intraperitoneal progression of tumor. It is a more difficult group of patients to treat with intraperitoneal therapy because of the aggressive and invasive nature of the tumors.
    id
    FG002
    title
    Adenocarcinoma of Gastrointestinal Origin
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        83
      2. group Id
        FG001
        num Subjects
        48
      3. group Id
        FG002
        num Subjects
        57
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        21
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        23
      type
      Not Evaluable
    3. achievements
      1. group Id
        FG000
        num Subjects
        61
      2. group Id
        FG001
        num Subjects
        39
      3. group Id
        FG002
        num Subjects
        35
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        22
      type
      NOT COMPLETED
    title
    Overall Study
recruitment Details
A total accrual of 203 was expected within approximately 5-6 years (59 patients for adenocarcinoma of gastrointestinal origin, other than low grade mucinous; 48 patients with low grade mucinous adenocarcinoma; and 96 patients with primary peritoneal mesothelioma).
Complete source fields
groups
  1. description
    Patients with peritoneal mesothelioma suffer with intractable ascites but have a very surface oriented tumor which usually does not invade into organs and cause organ dysfunction. The main source of symptoms and cause of death is intractable ascites.
    id
    FG000
    title
    Peritoneal Mesothelioma
  2. description
    Low grade mucinous adenocarcinoma also includes low grade mucinous neoplasms of borderline malignant potential. Patients with low grade mucinous adenocarcinoma can have prolonged survival with debulking surgery alone. The majority of patients with truly malignant disease will die of complications from intraperitoneal progression of tumor within 2 to 5 years. The tumors are often surface oriented within the peritoneal cavity without metastases to other distant sites. The most common origin for this type of tumor is the appendix and ovary.
    id
    FG001
    title
    Low Grade Mucinous Adenocarcinoma
  3. description
    Adenocarcinoma of gastrointestinal origin also includes other than low grade mucinous. Aggressive gastrointestinal adenocarcinomas such as gastric, small bowel, and colon cancer , tend to be more invasive into tissues and can more readily metastasize to distant sites. The cause of death is usually directly related to intraperitoneal progression of tumor. It is a more difficult group of patients to treat with intraperitoneal therapy because of the aggressive and invasive nature of the tumors.
    id
    FG002
    title
    Adenocarcinoma of Gastrointestinal Origin
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        83
      2. group Id
        FG001
        num Subjects
        48
      3. group Id
        FG002
        num Subjects
        57
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        21
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        23
      type
      Not Evaluable
    3. achievements
      1. group Id
        FG000
        num Subjects
        61
      2. group Id
        FG001
        num Subjects
        39
      3. group Id
        FG002
        num Subjects
        35
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        22
      type
      NOT COMPLETED
    title
    Overall Study
recruitment Details
A total accrual of 203 was expected within approximately 5-6 years (59 patients for adenocarcinoma of gastrointestinal origin, other than low grade mucinous; 48 patients with low grade mucinous adenocarcinoma; and 96 patients with primary peritoneal mesothelioma).

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice